caa a22 4500 38639962X CHVBK 20180307112153.0 cr unu---uuuuu 161130e198901 xx s 000 0 eng 10.1017/S0031182000072243 doi S0031182000072243 pii (NATIONALLICENCE)cambridge-10.1017/S0031182000072243 Modabber Farrokh UNDP/World Bank WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, CH 1211, Geneva 27, Switzerland Experiences with vaccines against cutaneous leishmaniasis: of men and mice [Elektronische Daten] [Farrokh Modabber] The need for a vaccine(s) against cutaneous leishmaniasis and the populations at risk for whom such vaccines should be developed are briefly discussed. The current human vaccine studies are reviewed, as are some experimental mouse studies with emphasis on Leishmania major infection relevant to vaccine development. Based on the information available from the mouse model and those data which are being sought in human studies, the benign nature of the cutaneous disease, the ease with which L. major can be manipulated to yield the required material, and the ongoing practice of leishmanization which allows rapid evaluation of candidate vaccine(s), it is suggested that a vaccine, at least against L. major, is imminent in the not too distant future. Copyright © Cambridge University Press 1989 cutaneous leishmaniasis nationallicence vaccines nationallicence Leishmania major nationallicence humans nationallicence mice nationallicence Parasitology Cambridge University Press 98/S1(1989-01), S49-S60 0031-1820 98:S1<S49 1989 98 PAR https://doi.org/10.1017/S0031182000072243 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1017/S0031182000072243 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Modabber Farrokh UNDP/World Bank WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, CH 1211, Geneva 27, Switzerland NATIONALLICENCE 773 0- Parasitology Cambridge University Press 98/S1(1989-01), S49-S60 0031-1820 98:S1<S49 1989 98 PAR CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-cambridge